FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

324585004: Nalidixic acid 300mg/5mL s/f suspension (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    465430013 Nalidixic acid 300mg/5mL s/f suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1190419013 Nalidixic acid 300mg/5mL s/f suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    465430013 Nalidixic acid 300mg/5mL s/f suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    718004013 Nalidixic acid 300mg/5mL s/f suspension (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1190419013 Nalidixic acid 300mg/5mL s/f suspension (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Nalidixic acid 300mg/5mL s/f suspension Is a Product containing nalidixic acid (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Nalidixic acid 300mg/5mL s/f suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Nalidixic acid (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Nalidixic acid 300mg/5mL s/f suspension Has manufactured dose form Oral suspension (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Nalidixic acid 300mg/5mL s/f suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
    Nalidixic acid 300mg/5mL s/f suspension Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start